ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanofi builds focus on rare blood disorders and cancers
November 30, 2018Rare blood disorders and blood-related cancers continue to be a major focus of research as scientists look for new treatments for serious and life-threatening conditions. -
Belgium’s Ablynx submits marketing authorisation application for caplacizumab approval
February 08, 2017Belgium-based Ablynx has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for approval of caplacizumab anti-von Willebrand factor (vWF) Nanobody to treat acquired thrombotic thrombocytopenic purpura (aTTP).
Pharma Sources Insight January 2025
